|  | No. | % |
---|---|---|---|
Healthy volunteers | (n = 15) | Â | Â |
 Age | median, range | 63 | 27-77 |
 Sex | Male | 7 | 46.7 |
Female | 8 | 53.3 | |
Non-cancerous patients | (n = 11) | Â | Â |
 Age | median, range | 53 | 35-79 |
 Sex | Male | 7 | 63.6 |
Female | 4 | 36.4 | |
Gastric cancer patients | (n = 55) | Â | Â |
 Age | median, range | 58 | 25-75 |
 Sex | Male | 36 | 65.5 |
Female | 19 | 34.5 | |
 Disease presentation | Recurrent | 14 | 25.5 |
Metastatic | 41 | 74.5 | |
 Type of surgery | Total gastrectomy | 9 | 16.4 |
Subtotal gastrectomy | 10 | 18.2 | |
No | 36 | 65.5 | |
 Differentiation | WD | 3 | 5.5 |
MD | 9 | 16.4 | |
PD | 27 | 49.1 | |
SRC | 12 | 21.8 | |
Othersa | 4 | 7.3 | |
 Lauren | Intestinal | 7 | 12.7 |
Diffuse | 10 | 18.2 | |
Mixed | 1 | 1.8 | |
Unknown | 37 | 67.3 | |
 HER2 | Negative | 46 | 83.6 |
Positive | 8 | 14.5 | |
Unknown | 1 | 1.8 | |
 Type of body fluid | Ascites | 46 | 83.6 |
Pleural fluid | 9 | 16.4 | |
 Previous palliative chemotherapy at acquisition of body fluid | Chemotherapy-naïve | 11 | 20.0 |
1 | 14 | 25.5 | |
2 | 15 | 27.3 | |
≥3 | 15 | 27.3 |